22nd Annual Highlights of the 2023 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations from the 2023 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
Join speakers from Fox Chase and Penn Medicine’s Abramson Cancer Center as they present information on the treatment of breast cancer, including screening, prevention, local control, chemotherapy, hormonal therapy, and advances in breast cancer biologics and their impact on breast cancer management.
DATE
Thursday, January 25, 2024
TIME
5:45–7:00 pm – Check-in & Reception (Buffet opens at 6:30)
7:00–9:00 pm – CME & Dinner
LOCATION
Philadelphia Marriott Old City
One Dock Street
Philadelphia, PA 19106
PROGRAM DIRECTOR & FACULTY
Angela Jain, MD
Assistant Professor, Department of Hematology/Oncology;
Interim Chief, Division of Breast Medical Oncology;
Chief, Division of Gynecologic Medical Oncology;
Fox Chase Cancer Center
Fox Chase Cancer Center Faculty
Penny R. Anderson, MD
Professor, Department of Radiation Oncology;
Chief, Division of Breast and Gynecologic Radiation Oncology;
Vice Chair for Quality Assurance and Process Improvement
Richard J. Bleicher, MD, FACS
Professor, Department of Surgical Oncology;
Clinical Director, Breast Service Line;
Director, Breast Fellowship Program
Melissa McShane, MD
Assistant Professor, Department of Hematology/Oncology;
Associate Program Director, Hematology/Oncology Fellowship Training Program
Fox Chase Cancer Center
Penn Medicine’s Abramson Cancer Center Faculty
Angela DeMichele, MD, MSCE
Professor of Medicine
Jill & Alan Miller Endowed Chair in Breast Cancer Excellence
Co-Leader, Breast Cancer Research Program
Co-Director, 2-PREVENT Translational Center of Excellence
Hayley M. Knollman, MD
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Learning Objectives
After attending this program, participants should be able to:
- Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant:
- Integrate new findings into the management of these patients.
- Apply new strategies for optimizing existing treatments into the management of these patients.
- Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.
INTENDED AUDIENCE
The program is designed for medical, surgical, and radiation oncologists; gynecologists; radiologists; fellows; residents; nurses; and healthcare professionals involved in the treatment of patients with breast cancer.
ACCREDITATION STATEMENT
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
DESIGNATION STATEMENT
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.
Inquiries
Lucía Tono, PhD, Med: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu